It has also been reported that Luteolin reduced Aβ pathology in AD mice by modulating APP processing, inhibiting Aβ generation, and mitigating neuronal damage through a PPARγ-dependent mechanism [70]. The gene discussed is PPARG; the disease is Alzheimer disease.